ADVM-053

Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate
CP Wire
Fri, 08/24/18 - 11:00 am
Adverum Biotechnologies
ADVM-053
hereditary angiodema
HAE
FDA
Adverum Biotechnologies Receives Orphan Drug Designation for Hereditary Angioedema Gene Therapy Candidate
Fri, 08/24/18 - 09:50 am
Adverum Biotechnologies
ADVM-053
hereditary angiodema